Cardiogenic shock is characterized by tissue hypoperfusion due to the inadequate cardiac
output to maintain the tissue oxygen demand. Despite some advances in cardiogenic shock …

Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical
evidence of tissue hypoperfusion and can lead to multi‐organ failure and death depending …

Cardiogenic shock is one of the most important complications of acute myocardial infarction
(MI) and acute left ventricular failure (LVF). It threatens the life of 5–10% of patients with ST …

Background: Cardiogenic shock (CS) is a life-threatening state of tissue hypoperfusion,
associated with a very high risk of mortality, despite intensive monitoring and modern …

Purpose Physician survey on cardiogenic shock management; recommendations for the
management of patients with cardiogenic shock are based mostly on experts' opinion …

Lo shock cardiogeno è uno stato di ipoperfusione tissutale derivante da un'insufficienza
cardiaca sinistra, destra o generale. La mortalità dei pazienti che sviluppano shock …

Cardiogenic shock is a leading cause of mortality in critical care units globally, despite
advances in research and medical management. This shock state is caused by an initial …

Cardiogenic shock (CS) is a complex condition characterized by end-organ hypoperfusion
and requiring pharmacologic and/or mechanical circulatory support. It is caused by a decline …

Cardiogenic shock (CS) is a complex condition causing end-organ hypoperfusion and high
mortality rates especially in patients with acute myocardial infarction. It remains a challenge …

Cardiogenic shock (CS) is characterized by low cardiac output and sustained tissue
hypoperfusion that may result in end-organ dysfunction and death. CS is associated with …